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Introduction
Breast cancer (BC) is the most commonly diagnosed type of cancer in women worldwide counting around 464 (28.8%) expected new cases per 100.000 in Europe [1] .
Axillary-lymph-node status is one of the most important prognostic predictors for breast cancer patients guiding loco-regional and systemic treatment decisions [2] .
Assessment of lymphatic mapping and sentinel lymph node biopsy (SNB) is now used to determine axillary node status as a 'golden standard' for patients with early-stage breast cancer with clinically negative axillary lymph nodes [3] .
In 1955, for the first time lymphatic mapping was presented by Seaman and Powers using radiolabeled colloidal gold to describe the path of lymphatic channels followed by cancer [4] . 'Sentinel lymph node' was defined as the first node to be involved in lymphatic spread by Gould et al in 1960 [5] . Finally, in 1992 Morton et al showed that SLN could accurately predict the potential for cancer in the associated basin [6] .
Neoadjuvant chemotherapy (NAC) is now used with increasing frequency not only for locally advanced but also for early stage breast cancer [7] . NAC is known to extend the opportunity for breast conserving surgery, improve cosmesis, enable assessment of NAC response, allow to downstage of the axillary status and provide research opportunities to better understanding the biology of breast cancer [8] .
Axillary lymph node dissection (ALND) still remains standard accepted surgical approach for patients following NAC regardless of primary lymph node status [9] . ALND is associated with significant morbidity and complications as lymphedema of the upper limb, pain, paresthesia, and restriction of motion of the shoulder girdle [10, 11] .
The optimal timing of SNB for breast cancer patients after NAC is still controversial [12] . As reported in SEN-TINA trial, lower detection rate ant higher false-negative rate of SNB in patients group after NAC was determined SVEIKATOS MOKSLAI / HEALTH SCIENCES IN EASTERN EUROPE ISSN 1392-6373 print / 2335-867X online 2016, 26 tomas, Nr. 5, p. 84-87 DOI: http://doi.org/10.5200/sm-hs.2016.077 BIOMEDICINA / BIOMEDICINE [2] . According to other authors, the higher false negative rate and the lower feasibility and accuracy of this procedure may be due to possible alterations to intramammary lymphatic drainage, potential multiple obscured and undetected sources of lymphatic drainage for larger tumors and possible non-uniform cytotoxic responses of axillary metastases [13] .
The aim of our retrospective study was to evaluate the predictable percentage of patients that could be eligible for SLNB after NAC in Klaipeda University Hospital Breast Surgery Department.
Patients and methods
From 2010 to 2014, 162 patients received NAC followed by breast surgery at Klaipeda University Hospital Breast Surgery Department. In all cases, the diagnoses were based on core needle biopsies before NAC. We allocated participants to two groups according to clinical (palpation and ultrasound) axillary node status before NAC (table 1) .
All breast cancer patients were scheduled for neoadjuvant chemotherapy with the type and length of chemotherapy left to the discretion of the treating medical oncologist.
After completion of NAC at the time of definitive breast surgery, all patients underwent ALND.
Results
A total of 162 patients with breast cancer, who received NAC was selected for the retrospective study. Before NAC, clinical LN status was negative in 21 cases (13%) and positive in 141 (87%).
According to clinical tumor status, 93 (57.4%) women were T2, 36 (22.2%) T3, 24 (14.8%) T4 and 9 (5.5 %) T1 respectively ( figure 1). 75 (46.3%) of patients underwent radical mastectomy, 63 (38.9%) quadrantectomy, 15 (9.3%) radical mastectomy with breast reconstruction, 9 (5.5%) quadrantectomy with simultaneous mastopexy of the other breast or reconstruction followed by ALND ( figure 2A and 2B) .
When evaluated postoperatively, pN0 in clinically 
Discussion
The ipsilateral axillar LN site is the most common site for breast cancer metastases either it is the most important prognostic factor [11] . Although ALND facilitates staging and provides good regional control, it is also associated with severe morbidities of breast cancer surgery [10] . Up to 73% of patients undergoing ALND develop complications, such as nerve injury, restricted shoulder motion, arm weakness, and infections due to the number of lymph nodes removed [14] . SLNB is established as standard procedure for evaluation of axillary LN status in early breast cancer without clinical lymphadenopathy with minimal complication rate [15] .
Since the usage of NAC is highly increased in earlystage and multifocal/-central breast cancer, the possibility of SLNB after NAC is widely discussed [16] . SLNB may now be offered in clinically LN negative breast cancer patients, however the usage in clinically LN positive patients is controversial [8] . In consent with other authors, pN0 in clinically LN negative group was detected postoperatively in 100.0% patients of our study. Nevertheless, ALND rates after NAC could be reduced because 20 to 40% of LN positive patients converts to LN negative at the time of operation [17] . Our study showed the same results in clinically LN positive group, pN0 was determined in 44.7% of cases.
Sentinel lymph node identification and false-negative (FN) rates in patients after NAC who initially had clinically node-positive breast cancer are the main aspects of concern [18] . NAC is thought to interfere with the anatomy and physiology of the lymphatic pathways by shrinkage and fibrosis of lymph vessels as well as obstructing them with cellular material or tumor emboli [13] . Therefore, according to the results of the studies of the American College of Surgeons Oncology Group (ACOZOG) Z1071 and SENTI-NA several suggestions are offered [2;3] .
Reliability of SLNB, that is determined by sentinel node identification rate was 92.7% (ACOZOG Z1071) and 87.8% (SENTINA) in patients with initially LN positive disease [2;3] . The accuracy of this procedure (e.g. falsenegative rate) was 14.2% [2] .
Firstly, in the studies concerning SLNB after NAC, the use of dual tracers is strongly recommended [2, 3] . Either, the combined use of additional mapping agent decreased the FN rate from 16.0% (SENTINA) and 22.2% (ACOZOG Z1071) to 8.6% and 10.8% respectively [2] .
Secondly, the significant relation between the number of sentinel nodes removed and the FN rate was established [18] . The FN rate was less than 10% for women who had three or more sentinel lymph node removed compared to 24.3% when one harvested [2] .
Thirdly, the placement of the ultrasound (US) guided clips and wires at the time of suspicious lymph node biopsy may increase the accuracy of SLNB and evaluation of response to chemotherapy [19] .
As the sentinel lymph node identification and FN rates in clinically node-positive breast cancer patients after NAC remain lower than in node-negative patients, the possibility of failure (to identify and to stage the axillary status) should be discussed and appropriate regional adjuvant treatment should be ensured.
Conclusions
In our study we have pointed out the results of LN status conversion after NAC. It is worth to decide performing SLNB after NAC in both clinically negative and positive patients. Optimal technique (dual mapping, more than three nodes removed and metastatic nodes marking before NAC) should be chosen in node-positive patients to assure the success of the procedure.
